Update - American Herbal Products Association (AHPA)

Technical Workshops

AHPA regularly presents in-person technical workshops to train the herbal products industry on the latest tools and methods that help ensure high-quality products and compliance with federal and state regulations.

Upcoming Events

FDA Releases Revised Draft of NDI Guidance

Revised draft replaces FDA’s 2011 draft

The Food and Drug Administration (FDA) today released revised draft guidance for new dietary ingredients (NDIs) to be published in the Federal Register on Friday. The revised draft replaces FDA’s 2011 draft.
0 Comments

Free AHPA-CRN Webinar: Brexit Impact on the Marketing of Food Supplements in the EU and UK

Presented in cooperation with IADSA

Recorded August 23, 2016. Member cost: Free. Nonmember cost: $99.

0 Comments

Congress Clears Federal Mandatory GMO Labeling Bill to Be Signed into Law

Federal law would preempt state GMO labeling requirements

AHPA President Michael McGuffin comments on bill's passage
0 Comments

FDA Issues Final Rule Amending Food Facility Registration Regulations

Rule effective date: September 12, 2016

On July 13, 2016, FDA issued the final rule, “Amendments to Registration of Food Facilities.” The final rule implements the food facilities registration provisions of section 415 of the Food Drug and Cosmetic Act, as amended by the Food Safety Modernization Act (FSMA); amends and updates Food and Drug Administration (FDA) registration regulations; and improves the utility of the food registration database.
0 Comments

Submit Updates for the Next Edition of AHPA's Herbs of Commerce

Deadline for submissions is Aug. 1

Herbs of Commerce 3rd Edition is coming. AHPA begins open call for updates and additions.
0 Comments

AHPA Presents on GACP and GMP for Herbal Ingredients at ACI Conference

AHPA leading industry consensus process for creation of self-regulatory initiatives

American Herbal Products Association (AHPA) President Michael McGuffin discussed development of good agricultural and collection practices (GACP) and good manufacturing practice (GMP) in the herbal ingredient supply chain on June 28 at the American Conference Institute's (ACI's) fourth annual Legal, Regulatory, and Compliance Forum on Dietary Supplements in New York City.
0 Comments

Wilson Lau to chair AHPA Board of Trustees

Lau replaces Graham Rigby

The American Herbal Products Association (AHPA) Executive Committee has appointed Wilson Lau as chair of the AHPA Board of Trustees until March 2017.
0 Comments

AHPA Opposes Blumenthal-Durbin Amendment to Restrict Some Supplement Sales on Military Bases

AHPA opposes separate regulatory standards that differ from existing general standards

“It is illogical as a regulatory principle and unworkable from a business perspective to require one set of rules for products sold through one channel of trade, such as stores on military bases, and another set of rules in the rest of the country,” said AHPA president, Michael McGuffin.
0 Comments

How to Choose a Contract Laboratory

Learn what factors to consider before selecting a contract lab and and how to get your testing completed correctly

Recorded May 18, 2016. Member cost: $199. Nonmember cost: $399.

0 Comments

AHPA Urges FDA to Define "Natural" to Promote Clarity and Consistency

Consumers should not be misled by inconsistent or inaccurate uses of "natural"

The American Herbal Products Association (AHPA) submitted comments to the Food and Drug Administration (FDA) yesterday encouraging the agency to establish, through rulemaking, a regulatory definition for the term "natural" (and possibly other terms, such as "100% natural" and "made with natural [named ingredient(s)]") for the labeling of human food products, and other products regulated by FDA such as animal foods, cosmetics, and botanical drugs.
0 Comments
RSS
First 3456789101112 Last

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.